← Back to Search

Neurofeedback for Schizophrenia

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of schizophrenia/schizoaffective disorder
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this variable will be assessed at t=0, 4 weeks, 8 weeks, 12 weeks and 4 weeks post completion of intervention
Awards & highlights

Study Summary

This trial will test a computer-based program to improve working memory in people with schizophrenia.

Who is the study for?
This trial is for individuals diagnosed with schizophrenia or schizoaffective disorder. It's not suitable for pregnant individuals, those who've changed medications in the last month, have a history of traumatic brain injury, active substance use disorders within the past month, or a seizure disorder.Check my eligibility
What is being tested?
The study is testing a new computer-based brain training program designed to improve working memory in patients with schizophrenia. The goal is to see if this neurofeedback intervention can lead to better outcomes and quality of life.See study design
What are the potential side effects?
Since the intervention involves non-invasive computer exercises, there are no direct physical side effects like you might expect from medication. However, participants may experience fatigue or frustration.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with schizophrenia or schizoaffective disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this variable will be assessed at t=0, 4 weeks, 8 weeks, 12 weeks and 4 weeks post completion of intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and this variable will be assessed at t=0, 4 weeks, 8 weeks, 12 weeks and 4 weeks post completion of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Task related Gamma band response (gamma coherence and power)
Secondary outcome measures
Change in Working memory

Trial Design

1Treatment groups
Experimental Treatment
Group I: Schizophrenia patientsExperimental Treatment1 Intervention
Thirty SCZ patients will receive neurofeedback to enhance gamma band response in an open-label, proof of concept study.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,114 Previous Clinical Trials
1,519,800 Total Patients Enrolled
27 Trials studying Schizophrenia
5,822 Patients Enrolled for Schizophrenia
National Institutes of Health (NIH)NIH
2,679 Previous Clinical Trials
6,910,602 Total Patients Enrolled
10 Trials studying Schizophrenia
1,394 Patients Enrolled for Schizophrenia

Media Library

Neurofeedback Clinical Trial Eligibility Overview. Trial Name: NCT03260257 — N/A
Schizophrenia Research Study Groups: Schizophrenia patients
Neurofeedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT03260257 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment count for this clinical trial?

"That is correct. Clinicaltrials.gov information demonstrates that this clinical trial, first posted on March 1st 2018, has openings for 80 patients across a single medical centre and are currently recruiting participants."

Answered by AI

Are there currently any opportunities to join this experiment?

"Affirmative, according to clinicaltrials.gov the recruitment process for this medical trial is still ongoing. The initial posting was on March 1st 2018 and the most recent update was made on March 28th 2022. An aggregate of 80 patients need to be enrolled at one site for this research project."

Answered by AI

Is this investigation available to participants younger than four decades of age?

"In order to be accepted into this trial, eligible participants must be between 18 and 65 years old. There are also 46 clinical trials for children under 18-years of age and 165 studies that cater to those over the age of 65."

Answered by AI

Could I potentially qualify for enrollment into this scientific testing?

"This clinical trial is open for 80 individuals suffering from schizophrenia and aged between 18 to 65."

Answered by AI
~11 spots leftby Mar 2025